1-8 of 8
Tiejun Gong
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Preliminary Efficacy and Safety Results of TQB3473, a Novel Syk Inhibitor, in Adult Patients with Immune Thrombocytopenia (ITP)

Hu Zhou, Bingjie Ding, Tiejun Gong, Xiangzhou Du, Xiaoming Li, Yinghui Lai, Zhenyu Yan, Rong Fu, Xin Du, Qian Zhao
Journal: Blood
Blood (2024) 144 (Supplement 1): 711.
https://doi.org/10.1182/blood-2024-198573
Published: 2024
Journal Articles

A Novel JAK2 Inhibitor OB756 in Treatment of Janus Kinase Inhibitor-Naive Patients with Myelofibrosis: A Phase 1/2, Open-Label, Multicenter Study

Yile Zhou, Jian Huang, Bingbing Wen, Hu Zhou, Wei Yang, Lianlian Fan, Tiejun Gong, Sujun Gao, Zongjiu Jiao, Qingchi Liu, Lidong Zhao, Guocai Wu, Cuicui Wu, Jun Wang, Jin Zhang, Jiaping Fu, Zengmei Sheng, Zunmin Zhu, Jian Lu, Yi Zhang, Jie Jin
Journal: Blood
Blood (2024) 144 (Supplement 1): 1808.
https://doi.org/10.1182/blood-2024-212216
Published: 2024
Journal Articles

First in-Class JAK2 Inhibitor OB756 Therapy for Patients with Polycythemia Vera : A Phase 2, Open-Label, Multicenter Study

Jian Huang, Bingbing Wen, Tiejun Gong, Hu Zhou, Lihong Shou, Qingchi Liu, Feng Zhang, Cuicui WU, Wei Yang, Lidong Zhao, Lili Chen, Jian Lu, Yile Zhou, Yi Zhang, Jie Jin
Journal: Blood
Blood (2024) 144 (Supplement 1): 3180.
https://doi.org/10.1182/blood-2024-210330
Published: 2024
Journal Articles

Mitoxantrone Hydrochloride Liposome Combined with Cytarabine As Induction Therapy for Patients with Newly Diagnosed Secondary Acute Myeloid Leukemia

Yun Wang, Weida Wang, Jingbo Xu, Ji Ma, Hua Wang, Bingyi Wu, Yuanbin Song, Weiran Lv, Lezong Chen, Jun Ma, Tiejun Gong, Yang Liang
Journal: Blood
Blood (2024) 144 (Supplement 1): 6074.
https://doi.org/10.1182/blood-2024-209055
Published: 2024
Journal Articles

Mitoxantrone Hydrochloride Liposome Containing Regimen in Patients with Adult Acute Lymphoblastic Leukemia: A Multicenter, Retrospective, Real-World Study

JUN MA, Tiejun Gong, Donglu Zhao, Xiaoyu Zhu, Xiaojing Yan, Junjie Ma, Yun Cai, HongXiang Wang, Mei Hong, Li Liu, Qiang Song, Xin Wang
Journal: Blood
Blood (2023) 142 (Supplement 1): 5897.
https://doi.org/10.1182/blood-2023-187864
Published: 2023
Journal Articles

A Multicenter Phase2 Trial of Linperlisib in Relapsed or Refractory Peripheral T/NK Cell Lymphomas

Yuqin Song, Zengjun Li, Huijing Wu, Jie Jin, Hui Zhou, Keshu Zhou, Liling Zhang, Zhigang Peng, Zhiye Zhang, Hong Cen, Youchao Jia, Yuerong Shuang, Zhiming Li, Haiyan Yang, Liqun Zou, Zhifeng Li, Zhihui Zhang, Junmin Li, Junning Cao, Lugui Qiu, Shaojie Wu, Tiejun Gong, Xiaohong Xu, Zhen Wang, Jun Zhu
Journal: Blood
Blood (2023) 142 (Supplement 1): 306.
https://doi.org/10.1182/blood-2023-180137
Published: 2023
Journal Articles

Update Results of a Phase II Trial of Venetoclax in Combination with Azacitidine and Chidamide in Relapsed/Refractory Acute Myeloid Leukemia

Jie Zha, Ying Wang, Zhenling Li, Zhijuan Lin, Yun Cai, Tiejun Gong, Wei Yang, Siting Xie, Zhenqi Huang, Pengcheng SHI, Lin Fu, Jinghua Wang, Xiangjun Fu, Xianqi Feng, Liping Su, Jianmin Luo, Lin Yang, Biyun Chen, Ying Xie, Yu Zhu, Xin Du, Yirong Jiang, Zhifeng Li, Bing Xu
Journal: Blood
Blood (2023) 142 (Supplement 1): 4274.
https://doi.org/10.1182/blood-2023-182832
Published: 2023
Journal Articles

Preclinical Studies and Phase II Trial of Venetoclax in Combination with Chidamide and Azacitidine in Relapsed/Refractory Acute Myeloid Leukemia

Jie Zha, Hui Zhou, Mengya Zhong, Ying Wang, Xin Du, Tiejun Gong, Zhijuan Lin, Yun Cai, Siting Xie, Chendi Xie, XianQi Feng, ZhenQi Huang, Liping Su, Jianmin Luo, Lin Yang, Zhenling Li, Bi-yun Chen, Ying Xie, Yu Zhu, Pengcheng Shi, Zhifeng Li, Yirong Jiang, Bing Xu
Journal: Blood
Blood (2022) 140 (Supplement 1): 3292–3293.
https://doi.org/10.1182/blood-2022-165261
Published: 2022